Lucas Franki is an associate editor for MDedge News, and has been with the company since 2014. He has a BA in English from Penn State University and is an Eagle Scout.
News
Gene therapy is bad business, and hugging chickens is just … bad
Plus, brains that can type and geologists who conduct kidney research.
News
A new take on breathing and a performance-enhancing placebo
Plus, a product that puts cleanliness next to snail-iness.
News
Canned diabetes prevention and a haunted COVID castle
Plus, a cheaper, fuzzier way to test for coronavirus.
News
Drinking your way to heart failure, and the fringe benefits of COVID-19 vaccination
Plus, loneliness as a health issue and high-flying, high-technology shirts.
News
Helpful giant rodents and our old friend, the hookworm
Plus, counting public restroom aerosols and raising less intelligent mice.
News
Seeing is bleeding, and smelling is perceiving
Plus, the twin joys of superfetation and Lady Liberty’s contribution to COVID-19 misinformation.
News
Life after death, and the case of the disappearing digit
Plus, Star Trek retractions and full placebo disclosure.
News
Match Day 2021: Pediatrics experiences slow, steady growth
Since 2017, pediatrics has offered more slots every year, rising from 2,738 in 2017 to 2,901 in 2021, an overall growth rate of just under 6%.
News
Match Day 2021: Dermatology holds steady
Available dermatology PGY-2 slots fell by 0.2% from 478 in 2020 to 477 in 2021, but 471 slots were filled in 2021, 2 more than last year.
News
FDA approves Qwo for treatment of cellulite
The first injectable cellulite treatment receives regulatory approval.
News
FDA approves Cosentyx for treatment of active nr-axSpA
The approval marks secukinumab’s fourth approved indication, following moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing...
News
FDA approves Uplizna for treatment of anti-AQP4 antibody–positive NMOSD
Second FDA-approved therapy for neuromyelitis optica spectrum disorder offers patients additional treatment option.
News
Baloxavir effective, well tolerated for influenza treatment in children
This phase 3 trial demonstrates that the investigational drug baloxavir marboxil is noninferior to oseltamivir, a drug for alleviating flu...
News
FDA approves new antibiotic for HABP/VABP treatment
Recarbrio was previously approved by the FDA to treat patients with complicated urinary tract infections and complicated intra-abdominal...
News
FDA approves ramucirumab-erlotinib combo for metastatic NSCLC
The approval was supported by results from the phase 3 RELAY trial.